| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-07 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.37 | 1e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |